Leaders of key Senate oversight committees are asking the Drug Enforcement Administration for details on its efforts to monitor the eligibility of individuals who are authorized to handle and prescribe controlled substances. The letter follows a Government Accountability Office report concluding that DEA needs better tools for ensuring that registrants who are at risk of illicit d... Read More